Now that summer is here and the school holidays are nearly upon us, many of us are planning time outdoors and travelling in ...

President Joel S. Schuman, MD, highlights the group’s mission and vision for the future—uniting 17 working groups and over 80 stakeholders.

In response to the CRL, the Company initiated a randomized, double-masked, vehicle-controlled dry eye chamber trial.

Karen Fernandez, MD, discusses the different types of treatment currently being tested for use in dry eye disease, which affects millions in the US.

Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax(R) Ophthalmic Suspension, 0.5%, of Bausch & ...